Duloxetine- A novel therapeutic regimen for trigeminal neuralgia

Abstract

Duloxetine is a potent and selective inhibitor of serotonin and noradrenaline transporters and a weak inhibitor of dopamine transporters. Duloxetine is highly protein bound and is widely distributed throughout tissues. It is rapidly and extensively metabolized in the liver by cytochrome P450 (CYP) 1A2 and 2D6 and its numerous metabolites which are inactive are mainly excreted in the urine. It is more effective for recurrent/refractory type of TN. Duloxetine holds the promise in complete remission of TN in future. So in coming days it may be a drug of choice for medical management of TN. This article is an insight in chemical features, pharmacodynamics, pathophysiology and therapeutics of Duloxetine.

Authors and Affiliations

Akhilanand Chaurasia

Keywords

Related Articles

Keratocystic tumor in mandibular body region

Odontogenic keratocyst(OKC) are developmental, non-inflammatory, chronic odontogenic cysts of epithelial origin derived from remnants of the dental lamina with a biologic behavior similar to that of benign neoplasm. The...

Analysis of mandibular fractures – a retrospective study

Aim The aim of the study was to analyse the incidence etiology and localization of mandibular fractures treated in the Department of Oral and Maxillofacial Surgery Govt Dental College Hospital Rajeev Gandhi Institute of...

Neem in Oral Diseases - An Update

Herbal Medicines are a fast emerging trend in recent times, as they provide safer, effcective and economical treatment to patients. Azadirachta indica (neem) has been an integral part of health and oral care since times...

Patterns of pediatric facial fractures: A five year retrospective study

Aim: The aim of this study was to analyze the patterns of facial fractures in children under 12 years of age admitted at oral and maxillofacial surgery department in Asser central hospital, Abha, Kingdom of Saudi Arabia...

Hypohidrotic ectodermal dysplasia- A case report

Ectodermal dysplasia is a hereditary disorder characterized by developmental dystrophies involving the ectodermal derivatives characterized by triad of signs comprising sparse hair missing or abnormal teeth and inability...

Download PDF file
  • EP ID EP295530
  • DOI 10.18231/2395-6194.2017.0053
  • Views 126
  • Downloads 0

How To Cite

Akhilanand Chaurasia (2017). Duloxetine- A novel therapeutic regimen for trigeminal neuralgia. Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology, 3(4), 222-224. https://www.europub.co.uk/articles/-A-295530